Profil
William S.
Korinek is the founder of Astrocyte Pharmaceuticals, Inc. since 2014, holding the title of Chief Executive Officer.
Current job includes Partner at Dreavent, Inc. Former job includes Vice President at Pfizer Inc. from 2009 to 2014.
Education includes a doctorate from Harvard University, conferred in 2000, and an undergraduate degree from Concordia College (Minnesota), conferred in 1995.
Aktive Positionen von William S. Korinek
| Unternehmen | Position | Beginn |
|---|---|---|
Astrocyte Pharmaceuticals, Inc.
Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Vorstandsvorsitzender | 01.08.2014 |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent invests in companies located in the United States. The firm targets companies operating in the fields of healthcare, biotech and life science sectors. It provides financing for early and later stage capital requirements. | Private Equity Investor | - |
Ehemalige bekannte Positionen von William S. Korinek
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Private Equity Investor | 01.07.2014 |
Ausbildung von William S. Korinek
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia College (Minnesota)
Concordia College (Minnesota) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astrocyte Pharmaceuticals, Inc.
Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent invests in companies located in the United States. The firm targets companies operating in the fields of healthcare, biotech and life science sectors. It provides financing for early and later stage capital requirements. | Finance |
















